The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform

CONCORDE Investigators

Research output: Contribution to journal › Editorial › peer-review

58 Downloads (Pure)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{0ea2f6304af34ef8be8cd7cd159f63fc,

title = "The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform",

author = "\{CONCORDE Investigators\} and C. Faivre-Finn and S. Brown and A. Ryan and A. Greystoke",

year = "2020",

month = feb,

day = "24",

doi = "10.1016/j.clon.2020.02.003",

language = "English",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials

T2 - Introducing the CONCORDE Platform

AU - CONCORDE Investigators

AU - Faivre-Finn, C.

AU - Brown, S.

AU - Ryan, A.

AU - Greystoke, A.

PY - 2020/2/24

Y1 - 2020/2/24

UR - https://www.scopus.com/pages/publications/85080049770

U2 - 10.1016/j.clon.2020.02.003

DO - 10.1016/j.clon.2020.02.003

M3 - Editorial

AN - SCOPUS:85080049770

SN - 0936-6555

JO - Clinical Oncology

JF - Clinical Oncology

ER -